Peptidoglycan (PG), the major component of the bacterial cell wall, is one large macromolecule. To allow for the different curvatures of PG at cell poles and division sites, there must be local differences in PG architecture and eventually also chemistry. Here we report such local differences in the Gram-positive rod-shaped model organism Bacillus subtilis. Singlecell analysis after antibiotic treatment and labeling of the cell wall with a fluorescent analogue of vancomycin or the fluorescent D-amino acid analogue (FDAA) HCC-amino-D-alanine revealed that PG at the septum contains muropeptides with unprocessed stem peptides (pentapeptides). Whereas these pentapeptides are normally shortened after incorporation into PG, this activity is reduced at division sites indicating either a lower local degree of PG crosslinking or a difference in PG composition, which could be a topological marker for other proteins. The pentapeptides remain partially unprocessed after division when they form the new pole of a cell. The accumulation of unprocessed PG at the division site is not caused by the activity of the cell division specific penicillin-binding protein 2B. To our knowledge, this is the first indication of local differences in the chemical composition of PG in Gram-positive bacteria.
Introduction
The bacterial cell wall is a structure unique to bacteria, providing shape and protection from environmental challenges to the cell. The main component of the cell wall is peptidoglycan (PG). PG is a large macromolecule composed of glycan strands connected by peptide cross-bridges that form a net-like structure (Typas et al., 2012; Turner et al., 2014; de Pedro and Cava, 2015; Randich and Brun, 2015) . Isolated PG molecules, socalled sacculi, retain the shape of the cell they surrounded (H€ oltje, 1998) . PG is constantly remodeled to allow the bacterial cell to expand its volume, to divide, and to allow the attachment of other molecules such as teichoic acid, or to allow the incorporation of proteins that cross the PG layer (e.g., pili, flagella) (H€ oltje, 1998) . PG grows by the incorporation of LipidII precursor molecules, composed of a disaccharide with a pentapeptide side chain, connected to a bactoprenol carrier molecule that anchors the building block to the membrane. The disaccharide moiety is coupled to a glycan strand by a glycosyl transferase and released from the carrier, and the pentapeptide moiety can be crosslinked to peptides on different strands by transpeptidases.
The pentapeptide composition differs between bacteria, for instance in Bacillus subtilis the pentapeptide is composed of L-Ala-D-Glu-L-meso-diaminopimelic acid-D-Ala-D-Ala, but the method of the primary DD-crosslink formation is very similar: the D-amino acid on the 4th position of one pentapeptide is covalently attached to the crosslinking protein (a transpeptidase), with concurrent release of the 5th D-amino acid on the pentapeptide. The donor peptide is subsequently crosslinked to the 3rd amino acid on the acceptor pentapeptide, generally an amino acid containing a free amino group, such as meso-diaminopimelic acid or L-lysine. Additionally, L,D-crosslinks can be formed between two amino acids at position 3, although these crosslinks are neither universal nor do they appear to be essential (Magnet et al., 2008; Cava et al., 2011) . Not all peptides are used in crosslinks, and unlinked pentapeptides are generally modified to tetra-or tripeptides, except in some bacteria such as Staphylococcus aureus that contains a very large amount of free pentapeptides (de Jonge et al., 1992) . In S. aureus, the degree of PG crosslinking is a determinant for antibiotic resistance, with lower crosslinking resulting in higher antibiotic sensitivity (Memmi et al., 2008) , through a yet unknown mechanism, which may have to do with easier access to the antibiotic target, or an overall weaker PG structure.
PG is one large molecule, and its synthesis and turnover are controlled by a large group of enzymes that coordinate these activities on various locations along the bacterial cell wall. In rod-shaped bacteria, two complexes for PG synthesis have been identified, the 'elongasome' and the 'divisome', responsible for PG synthesis along the lateral wall and at the cell division site respectively (Typas et al., 2012; Szwedziak and Lowe, 2013; Randich and Brun, 2015) . These two machines are coordinated by the cytoskeletal proteins MreB and FtsZ and consist of LipidII synthetases, flippases, membrane proteins with unknown coordinating functions such as MreC/D and RodZ, proteins from the Shape, Elongation, Division and Sporulation (SEDS) family and Penicillin Binding Proteins (PBPs). SEDS and PBPs are the proteins that incorporate LipidII molecules into PG. SEDS proteins, such as FtsW and RodA, have glycosyl transferase activity (Cho et al., 2016; Meeske et al., 2016) . PBPs are divided into two groups: highmolecular-weight (HMW) and low-molecular-weight (LMW) PBPs. HMW PBPs are further classified into class A PBPs, whose members show glycosyl transferase and transpeptidation activity, and class B PBPs, whose members only have transpeptidation activity. The LMW PBPs have various activities, such as DDcarboxypeptidase, transpeptidase or endopeptidase activity, but always one activity per enzyme (Scheffers and Pinho, 2005) .
The different machineries involved in PG synthesis and the different structural requirements to PG on different locations in the cell, suggest that the composition of PG may vary along the sacculus. Atomic force microscopy showed that there are local differences in PG architecture between division sites and other places along the bacterial wall, which vary in thickness or in patterning (Hayhurst et al., 2008; Turner et al., 2014) . However, this technique does not reveal the underlying chemistry or crosslinking degree. Fluorescent labeling methods have uncovered different PG growth modes used by different bacteria (Kuru et al., 2012; Typas et al., 2012; Pinho et al., 2013; Cameron et al., 2015) , yet what happens after the insertion of LipidII is unclear. Currently, local modifications to PG and local changes to the crosslinking degree cannot be identified as the methods to analyze PG composition provide only information on population averages (Turner et al., 2014) .
In this study, we use a combination of antibiotics treatment and labeling of the cell wall with a fluorescent analogue of vancomycin ( Van-FL) or the fluorescent Damino acid analogue (FDAA) HCC-amino-D-alanine (HADA). Van-FL binds to the terminal D-Ala-D-Ala of the disaccharide pentapeptide subunit , whereas HADA is incorporated at the 5th position in Bacillus subtilis stem-peptides and rapidly processed after incorporation (Kuru et al., 2012) , so both labeling methods only reveal unincorporated LipidII and newly synthesized PG. We found that septal PG is rich in pentapeptides, and that these pentapeptides remain partially unprocessed after division when they form the new pole of a cell. Mature PG contains only a small number of pentapeptides, 3.7% of total muropeptides of which 1.6% contains a terminal D-Ala and 2.1% a glycine residue at position 5 (Atrih et al., 1999) . This is the first indication of local differences in the chemical composition of PG in Gram-positive bacteria. Our findings reveal that there are local differences in PG crosslinking and processing throughout the cell wall.
Results

PG at the division site contains high concentrations of pentapeptides
We used fosfomycin to block LipidII synthesis, and then stained nascent PG with Van-FL. To our surprise, 20 min treatment with fosfomycin at a concentration that blocks synthesis of new LipidII and PG (DominguezEscobar et al., 2011; Garner et al., 2011) , does not completely block Van-FL labeling of cells (Fig. 1A) , something that would be expected if Van-FL predominantly labels LipidII. Daniel and Errington ) also observed continued Van-FL labeling of cells that were treated with various antibiotics that block LipidII synthesis, and interpreted this as an incomplete block of LipidII synthesis. Bacitracin treatment had a stronger effect on reduction of Van-FL staining than fosfomycin . We decided to investigate this phenomenon in more detail, using both Van-FL and the newly developed D-Ala analogue HADA, which in B. subtilis is incorporated exclusively in the 5th position of the stem peptide (Kuru et al., 2012 ) (Supporting Information Fig. S1 ). Van-FL and HADA labeling both report the presence of a pentapeptide, but Van-FL can label pentapeptides that are already present before the label is added, whereas HADA labeling depends on active LipidII/PG synthesis.
B. subtilis grown in the presence of either fosfomycin, bacitracin or D-cycloserine for 20 min prior to labeling with Van-FL, showed strong labeling at the division site (Fig. 1A) . None of these treatments killed the cells within the 20 min timeframe of the experiment as determined by both membrane permeability measurements as well as dilutions of treated cells, although prolonged exposure (60 min) did have an effect (Supporting Information Table S1 , Fig. S2 ). Quantification of the fluorescence signals at the septum revealed that fluorescence was increased when cells were treated with fosfomycin and bacitracin, but not when cells were treated with Dcycloserine (Supporting Information Fig. S3 ). We cannot explain the increase in Van-FL signal but do note that also the background signal was higher in the fosfomycin and bacitracin stained samples. There are various possible explanations for the septal labeling pattern, which could also occur in combinations. First, if the antibioticinduced block of LipidII synthesis is incomplete, this could cause accumulation of LipidII. Second, LipidII at the division site may no longer be incorporated into PG and/or processed during the 20 min period in which PG synthesis is blocked. Third, bacitracin and fosfomycin inhibit the activity of carboxypeptidases that cleave DAla at position 5. Fourth, Van-FL could label existing PG material, not LipidII, of which the pentapeptide has not been processed as the donor in crosslinking or through cleavage of the 5th D-Ala. To distinguish between these explanations, we repeated the experiment with HADA labeling. Fosfomycin treatment resulted in a near complete block of HADA incorporation, and bacitracin and D-cycloserine completely abolished HADA incorporation (Fig. 1A) , indicating that, in fact, the antibiotic treatments efficiently block LipidII synthesis. This result strongly suggests that the Van-FL label observed at the division site is not caused by the staining of residual LipidII that was synthesized during the antibiotic treatment. Then, in a reverse experiment, cells were labeled with HADA before resuspension in growth medium for 20 min in the presence of fosfomycin, bacitracin or D-cycloserine. Cells treated in this manner showed strong division-site labeling, similar to the Van-FL labeling (Fig. 1B) , indicating that HADA is incorporated into the cell wall, but then fails to be processed at the division site. HADA labeling followed by 20 min of growth without antibiotics also resulted in septal labeling, indicating that the retention of label is not the result of blocked PG synthesis or processing (Fig. 1B  top panel) . Comparison of the level of HADA fluorescence at the septa indicated that the levels of fluorescence were similar for all cells analyzed (Supporting Information Fig. S3 ). Fig. 1 . Accumulation of unprocessed pentapeptides at the septum. Exponentially growing B. subtilis (168) was either labeled with Van-Fl or HADA after growth for 20 min in the absence (control) or presence of fosfomycin (500 lg/ml) bacitracin (500 lg/ ml) or D-cycloserine (500 lg/ml) to block LipidII synthesis (A). In a reverse experiment, cells were labeled with HADA for 5 min and allowed to continue growth for 20 min in the presence of fosfomycin or bacitracin (B). Arrows indicate labeled septa. Scale bar (same for all): 5 lm. Kuru et al. (2012) used a B. subtilis dacA (PBP5) knockout strain to visualize PG along the lateral wall. PBP5 is the major D,D-carboxypeptidase of B. subtilis which contributes to PG maturation by removing the majority of terminal D-Ala residues from stem peptides that were not used as donors in crosslinking reactions (Atrih et al., 1999) . We repeated the labeling experiments in a dacA knockout strain, to see if we could increase the labeling, especially at the lateral wall. As expected, both HADA and Van-FL labeling at the lateral wall increased due to the increase of unprocessed pentapeptides in PG ( Fig. 2A and D) . Van-FL labeled the entire cell circumference, which can be explained by the fact that Van-FL labels all D-Ala-D-Ala residues in the wall. HADA resulted in a patchy pattern on the lateral wall, as it is only labeling material synthesized during the 5 min labeling pulse. Blocking PG synthesis with bacitracin, again almost completely blocked HADA incorporation all over the cells (Fig. 2B ), whereas Van-FL still labeled the cell circumference ( Fig. 2E ), indicating that this labeling pattern reflected primarily PG, not LipidII. Again, when cells were labeled with HADA before blocking PG synthesis, label was retained at the division site, indicative of absence of processing at the division site (Fig. 2C) .
It has been reported that in some bacteria the incorporation of fluorescent D-amino acids occurs primarily through exchange reactions on the outside of the cell, and thus that the FDAA is not incorporated into LipidII itself (Kuru et al., 2012; Tsui et al., 2014) . In B. subtilis, the major PBP responsible for such an exchange reaction is PBP4, in the absence of which incorporation of various NBD-labeled D-amino acid analogues is reduced but not blocked (Fura et al., 2015) . We confirmed that this was the same for HADA-labeling: although overall labeling was somewhat reduced in a PBP4 knockout strain, septal labeling was still clearly detectable (Supporting Information Fig. S4 ). Treatment of cells with D-cycloserine, which blocks incorporation of D-Ala into LipidII, completely blocked HADA-labeling of cells (Fig. 1A) . Fosfomycin, which blocks LipidII synthesis but not transpeptidase activity, causes a block of HADA labeling in B. subtilis (Fig. 1A) . In Escherichia coli, where all incorporation occurs via transpeptidation (Kuru et al., 2012 , cells could still be labeled with HADA after a 20 min treatment with fosfomycin (Supporting Information Fig. S5 ). Finally, our results in B. subtilis 168 were not strain-specific as HADA labeling of strain PY79 gave similar results (Supporting Information Fig. S5 ). Combined, these controls suggest that at least part of the HADA-labeling in B. subtilis occurs via the LipidII route.
Division-site labeling is caused by accumulated pentapeptides, not unincorporated LipidII
Although the above results indicate that it is unlikely that the Van-FL/HADA fluorescence observed at the division site is produced by an accumulation of LipidII, we wanted to confirm that the labeling pattern reflects material that has been incorporated into PG. To do so, we isolated sacculi from HADA-labeled and non-labeled cells. The isolation of sacculi involves boiling the cells repeatedly in SDS and treatment with hydrofluoric acid, which should remove all membrane associated LipidII and wallassociated polysaccharides. Sacculi isolated from HADAlabeled cells displayed clear HADA labeling in rings at the division sites, indicative of PG with a high concentration of pentapeptides at the division site (Fig. 3A) . Sacculi isolated from non-labeled cells, which were subsequently labeled with Van-FL displayed a similar labeling pattern (Fig. 3B) , although in addition to division rings, polar fluorescence was also occasionally detected. Sacculi were also isolated from cells that were grown for 20 min in the presence of bacitracin, fosfomycin or D-cycloserine. When these sacculi were labeled with Van-FL similar patterns were observed as for the cells grown in the absence of antibiotics (Fig. 3D, F , and H). Finally, sacculi isolated from cells that were HADA-labeled and then grown for an additional 20 min in the presence of bacitracin, fosfomycin or D-cycloserine also still showed rings (Fig. 3C , E, G). This result shows that the accumulation of pentapeptide material at the septum is not caused by an accumulation of LipidII or the result of antibiotic treatment. As a final control for HADA incorporation into PG, HADA-labeled sacculi were incubated with lysozyme and the fluorescence was followed over time (Fig. 4) . Lysozyme digests the 1,4-b-glycosidic bond between MurNAc and GlcNAc, therefore if the fluorescence is caused by HADA that is incorporated into PG, the signal at the septum should decrease over time as PG fragments are released by lysozyme. Lysozyme digestion was followed for 10 min, with an untreated sample as a control for bleaching. The fluorescence at the division site of the sacculi treated with lysozyme decreased over time, compared to the untreated control (Fig. 4 , compare signals at arrows between top and bottom rows). Combined, these results show that the HADA-label is incorporated into the PG and that there is an accumulation of unprocessed DAla-D-Ala at division sites.
3D structure of the pentapeptide rings
To visualize the 3D structure of the pentapeptide containing PG at the division site in live cells, Z-stack pictures of HADA-labeled B. subtilis in exponential phase were taken, followed by deconvolution and 3D reconstruction. Figure 5 shows that the labeled muropeptides at the division site form a structure similar to a ring, comparable to what was observed with sacculi ( Fig. 3) . This kind of donut-shaped ring structure also looks like the structure of the B. subtilis septum obtained with atomic force microscopy (Hayhurst et al., 2008) . In addition, Kuru et al. showed that E. coli, Agrobacterium tumefaciens and S. aureus also present a ring at the division site when labeled with a short HADA pulse (2012).
Pentapeptides at the division sites are retained at the poles and eventually processed
We used fluorescence time-lapse microscopy to determine if the pentapeptide-enriched PG at the septum is processed. Exponentially growing B. subtilis cells were labeled with a short pulse of HADA, and B. subtilis growth was followed by fluorescence time-lapse microscopy (Fig. 6) . At the initial stage, HADA labeling is localized as a band at the septum and the signal stays strong in agreement with our previous results. As the size of the cells increases and the septum starts to become two new poles, the HADA signal decreases indicating that some HADA-labeled material is processed. Interestingly, after the cells have split, some HADA signal is retained in both new cells at the poles, suggesting that crosslinked muropeptides containing HADA are integrated to the cell wall at the poles. Fluorescence at the poles was also conserved in the next generation. These results are similar to those obtained with E. coli by de Pedro et al. (1997) , confirming that the material incorporated into the poles is highly stable, and to a recent study from the Winkler lab where retention of HADA at cell poles was observed (Boersma et al., 2015) .
Next, we investigated whether it was possible to increase polar HADA labeling. Deletion of both ezrA and gpsB has been reported to lead to polar retention of PBP1 and ongoing polar PG synthesis as reported by Van-FL staining (Claessen et al., 2008) . Van-FL labeling of ezrA gpsB double mutant cells indeed resulted in fluorescent labeling of the cell poles, as expected (Fig. 7) and was not observed with the single deletions as reported (not shown). However, with HADA no polar labeling was observed (Fig 7) . We confirmed this observation by analyzing the fluorescence distribution along the length of the cell which showed that cells labeled with Van-FL have increased labeling at the poles which is completely absent from HADA-labeled cells, whereas increased labeling at division septa and at 1/4 and 3/4 positions along the length of the cells was observed with both labeling methods (Fig. 7) . As HADA labeling requires active PG synthesis this result strongly suggests that it takes cells longer to process pentapeptides present in polar PG in the absence of ezrA and gpsB, but also that the polar Van-FL labeling is not the result of ongoing synthesis at the poles. In addition, this result (together with those from the dacA mutant, Fig. 2) shows that in the absence of antibiotics, it is possible to obtain different labeling patterns for Van-FL and HADA. Again, this indicates that Van-FL labels existing pentapeptides whereas HADA only reports on newly synthesized pentapeptides.
Pentapeptides at the septum are not involved in PBP2B localization
Cell division requires the activity of a specific Class B transpeptidase, PBP2B in B. subtilis (Daniel et al., 1996) . Presence of this protein is essential for division and in its absence other cell division proteins, collectively known as the divisome, also lose their localization at the division site (Daniel et al., 2000) . PBP2x, the PBP2B homologue of Streptococcus pneumoniae, is required for labeling of the constricting septa with FDAAs (Tsui et al., 2014) . In addition, the localization of PBP2x to midcell is dependent on its PASTA domains (Peters et al., 2014) . PASTA domains are capable of binding uncrosslinked muropeptides albeit with low (millimolar) affinity (Shah et al., 2008; Paracuellos et al., 2010; Maestro et al., 2011; Mir et al., 2011; Squeglia et al., 2011; Peters et al., 2014) . We wanted to investigate whether the cell-division-specific activity of PBP2B, which contains two C-terminal PASTA domains, is responsible for generating the pentapeptide-enriched PG at the septum, and/or whether the PASTA domains of PBP2B are responsible for the localization of PBP2B to the septum.
GFP-PBP2B localization was not affected by bacitracin treatment, showing that a block in LipidII synthesis does not affect the assembly of the divisome (Supporting Information Fig. S6 ). We then generated a set of strains in which native PBP2B is produced in the presence of IPTG and GFP-PBP variants are produced in the presence of xylose (Fig. 8A) . This allowed us to simultaneously check the capacity of the GFP-PBP2B Unprocessed PG at B. subtilis division sites 325 variants to complement the depletion of wild type PBP2B, as well as their localization. In addition to a truncation of the PASTA domains, we also created a transpeptidase-inactive mutant by changing the catalytic serine (Ser312) to alanine, and combined the catalytic site mutant with the PASTA truncation. As a control, we made a 'supertruncate' variant in which most of the PBP2B was removed.
As expected, depletion of PBP2B was lethal and expression of the GFP-supertruncate construct did not rescue this phenotype. To our surprise, all other GFP-PBP2B variants allowed cells to grow with growth rates similar to wild type GFP-PBP2B (Supporting Information   Fig. S7 ). To make sure that the complementation was not an artifact of the GFP-fusion, a second set of strains with the pbpB alleles alone was created. Again, all constructs except the supertruncate complemented the depletion of pbpB (Supporting Information Fig. S7 ). The expression level of the GFP-PBP2B constructs was similar in all strains, as evidenced by the levels of in-gel GFP fluorescence. Mutation of the catalytic Ser312 was confirmed, since the active-site mutants no longer bound Bocillin-FL, which requires the catalytic serine for covalent attachment (Supporting Information Fig. S8 ). When we analyzed the mutant strains for localization of the GFP-PBP2B variants, we noticed that none of the strains showed strong cell-division defects, and that all the GFP-PBP2B variants still preferentially localized to the septum, meaning that neither the PASTA domains, nor the catalytic serine are required for PBP2B localization (Fig. 8B) . Labeling of the cells with HADA revealed strong septal labeling in all cases, showing that the transpeptidase activity of PBP2B is not required for the accumulation of pentapeptide-containing PG at the septum (Fig 8B) .
Discussion
Although PG is one large macromolecule, it has long been known that there are local differences in PG architecture and possibly chemistry. The architecture of PG needs to be different to allow for the different curvatures of the sacculus at poles and division sites. Early electron microscopy studies of the B. subtilis cell wall have already shown wall bands at the division site (Burdett and Higgins, 1978) , and different PG growth modes at the poles (Clarke-Sturman et al., 1989). Atomic force microscopy revealed cable-like structures on the B. subtilis lateral wall and thick, defined septa (Hayhurst et al., 2008) . It has been well documented that next to regions of high PG turnover, there are regions of so-called inert PG (iPG) in E. coli, which play an important role in keeping the shape of the cells as improperly located iPG can be found at branching points in shape mutants (de Pedro et al., 2003; Potluri et al., 2012) . Determining the underlying chemistry of local differences in PG synthesis, i.e., the level of crosslinking and processing of muropeptides at different sites in the sacculus, has so far been difficult as methods addressing these matters rely on bulk analysis of digested PG molecules by HPLC and LC/MS (Turner et al., 2014) . The exciting development of FDAAs to label PG synthesis (Kuru et al., 2012) has made it possible to start addressing such local differences at the single-cell level.
Using the unique properties of HADA, namely its incorporation into the 5th position of the stem peptide in B. subtilis PG and rapid processing at the lateral wall by PBP5 (Kuru et al., 2012) (Fig. 2, Supporting Information  Fig. S1 ), we show that there is a population of stable, pentapeptide-containing PG at the division site in B. subtilis. The labeling patterns observed with HADA are very similar to patterns observed with Van-FL after labeling unmodified PG, and thus these patterns are truly reflective of the presence of D-Ala-D-Ala moieties at the division septum. This also explains why Van-FL labeling still reveals the division site when cell-wall synthesis is blocked with various antibiotics as shown here and by Daniel and Errington (Daniel and Errington, 2003) , or when cell-wall synthesis is blocked by the addition of CCCP (Strahl et al., 2014) , which delocalizes various proteins involved in PG synthesis such as MreB and PBP1 (Strahl and Hamoen, 2010; Lages et al., 2013) . Importantly, the presence of pentapeptidecontaining septal PG was confirmed by the observation that Van-FL labeled sacculi isolated from untreated cells at the septa. This indicates that the presence of pentapeptides at the septum is not the result of an accumulation of pentapeptides at the septum caused by HADA or Van-FL labeling of live, growing cells. Also, HADA-label was retained upon isolation of sacculi and was released by lysozyme treatment, indicating that the observed HADA-label is incorporated into PG. Some of the unprocessed PG observed at the division site is retained at the cell poles and probably part of iPG in B. subtilis, as was recently also noted in time-lapse experiments with B. subtilis PY79 where the focus was on PG turnover at the lateral wall (Boersma et al., 2015) . However, there must be some processing of the septal material upon splitting of the cells as the label observed at the poles is never as strong as at the septum, and we also do not see consistent labeling of all poles with Van-FL. Our results suggest that PG at the poles is slowly converted into 'true' polar, inert PG, and that this processing is affected in a ezrA gpsB double deletion strain. This implies that PG chemistry at the pole depends on the age of the pole. Accumulation of pentapeptides at the septum has previously been proposed for S. pneumoniae, as its main DD-carboxypeptidase was found to be absent from the septum (Morlot et al., 2004) , but to our knowledge, our report is the first to convincingly show the presence and persistence of pentapeptides at the septum. This does not mean that this septal material is not crosslinked, as the D-Ala-D-Ala moiety can remain attached to an acceptor stem peptide. This is also evidenced by the finding of the HADA label in the two major pentapeptide containing muropeptide peaks during HPLC analysis of a dacA mutant (Supporting Information Fig. S1 ).
PG that is incorporated at the lateral wall is processed rapidly, primarily by the major DD-carboxypeptidase PBP5. Retention of D-Ala-D-Ala containing PG at the septum thus suggests that PBP5 is absent from, or not active at the division site. A GFP-fusion to PBP5 is localized both at the septum and at the lateral wall (Scheffers et al., 2004) , indicating that the activity of PBP5 may somehow be blocked at the division site. In E. coli, PBP5 and FtsZ act together (Varma and Young, 2004) and it seems to be the absence of PBP5 at midcell, and thus the presence of pentapeptides, that allows for a correct placement of the FtsZ-ring ensuring correct cell division and cell shape in the following generations (Potluri et al., 2012) . B. subtilis does not show dramatic shape defects in the absence of DD-carboxypeptidases, but this may be because the septal PG is thick, splits rather than invaginates, and because septum shape is coordinated by other proteins that are absent from E. coli such as SepF (Gundogdu et al., 2011) . How the presence of pentapeptides at the division site is communicated to FtsZ on the inside of the cell is unknown, but this may be through divisome components on either side of the membrane. A candidate protein that could connect unprocessed PG and FtsZ is PBP2B, a Class B transpeptidase that is essential for formation of the septum (Daniel et al., 1996 (Daniel et al., , 2000 , as this protein contains two PASTA domains that have been implicated in binding of uncrosslinked muropeptides (Shah et al., 2008; Paracuellos et al., 2010; Maestro et al., 2011; Mir et al., 2011; Squeglia et al., 2011; Peters et al., 2014) . Recently, the localization of the essential S. pneumoniae PBP2x (homologue of PBP2B) was reported to be dependent on either its own C-terminal PASTA domains, or the presence of PASTA domains on its interacting partner StkP (Morlot et al., 2013; Peters et al., 2014) . Removal of the PASTA domains from PBP2B did not abolish localization of PBP2B nor did it affect its function. To our surprise, replacement of the active-site serine also did not affect localization or function, and even a PBP2B construct lacking both the active site serine and the PASTA domains was functional in that it allowed cells to grow, localized to the division site and showed PG labeling similar to wild type cells. We cannot formally exclude the possibility that a minute amount of wild type PBP2B is produced in the depletion strain, which, in turn, only rescues this strain when other inactive forms of GFP-PBP2B are expressed. However, as growth rates and localization patterns of the catalytically inactive variants are indistinguishable from the wild type GFP fusion, and complementation was dependent on xylose, we deem this unlikely. Also, a construct in which most of the protein was deleted was not capable of complementing a PBP2B depletion strain. It seems that it is not the transpeptidase activity of PBP2B that is essential, but rather that the presence of the protein in the divisome is required and that its catalytic activity can be compensated by another, non-essential transpeptidase. In this respect, it is important to note that depletion of any component of the B. subtilis divisome results in destabilization and delocalization of the other components .
The discovery of the accumulation of pentapeptidecontaining PG may seem paradoxical as it was recently reported that proteins containing SPOR domains, that bind to 'denuded' PG, which is devoid of stem-peptides, localize to the septal site of sacculi isolated from both B. subtilis and E. coli (Yahashiri et al., 2015) . However, it is easy to envisage that 'denuded', i.e., extremely processed, PG, and unprocessed PG coexist at the septum -while at the same time noting that we could not observe unprocessed PG in E. coli. In B. subtilis, D-Ala-D-Ala containing pentapeptides comprise only a small portion of the total PG, and even when all this material is concentrated at the septum, this would mean that a large fraction of the muropeptides at the septum are processed, for example because the stem-peptide served as a donor in a crosslinking reaction.
It remains to be established what the specific function of the pentapeptides at the septum is and how the relative lack of stem-peptide processing at the septum is regulated. We are currently investigating this.
Experimental procedures
Bacterial strains and growth conditions
Strains used in this study are listed in Table 1 . All Bacillus strains were grown in casein hydrolysate (CH)-medium at 308C (Anagnostopoulos and Spizizen, 1961; Harwood and Cutting, 1990) . Strain 3122 was induced by adding 0.5% (w/v) xylose and strain 4055 with 0.02 mM IPTG. Strain 4056 (dacA::kan) was constructed by transformation of B. subtilis 168 with chromosomal DNA of B. subtilis DK654 (kind gift from Dan Kearns, Indiana University Bloomington). Deletion of dacA (PBP5) was confirmed by PCR and labeling with Bocillin-FL (Life-Technologies).
Construction of GFP-PBP2b mutants and strains
The coding sequences for full length pbpB and pbpB1-1991 were amplified from B. subtilis 168 chromosomal DNA using primers djs501 (5 0 -GTCGGATCCCTATGATTCAAAT GCCAAAAAAG) and djs502 (5 0 -GAACTCGAGTTAATCAG GATTTTTAAACTTAACC) or djs503 (5 0 -GAACTCGAGTT ATTCTTCCTTATCTGAGTCAG) respectively (503 introduces a stop codon after position 1991) and subcloned into pGEM-T (Promega). After sequencing, the PCR fragments were cloned using BamHI/XhoI into pSG1729 (Lewis and Marston, 1999) , resulting in plasmids pDMA001 (gfp-pbpB) and pDMA002 (gfp-pbpBDPASTA). pDMA001 and pDMA002 were used as template plasmids in a Quickchange PCR (Stratagene) to introduce mutation pbpBT 934G changing the catalytic Ser312 to Ala using primers djs504 (5 0 -GTATGAACCCGGGGCCACGATGAAGATC) and djs505 (5 0 -GATCTTCATCGTGGCCCCGGGTTCATAC) resulting in plasmids pDMA003 (gfp-pbpBSer312Ala) and pDMA004 (gfp-pbpBSer312Ala-DPASTA). All plasmids were sequence verified. Sequence verification of an initial PCR product generated using djs501/502 revealed the introduction of a G676A mutation resulting in a stop codon at position 222. This 'pbpB-supertruncate' construct was subcloned into pSG1729, generating pDMA005, to serve as a negative control in complementation assays. All plasmids were cloned into B. subtilis 3295 and integration into the amyE locus was verified by growing the transformants on starch plates. To remove gfp from pDMA001, pDMA002, pDMA003, pDMA004 and pDMA005, these plasmids were digested using KpnI and BamHI. Plasmid and gfp DNA fragments were separated on agarose gels, plasmid DNA was isolated and the overhangs were filled using DNA Blunt enzyme (Thermo Scientific) and the linear plasmids were religated. All plasmids were sequenced and cloned into B. subtilis 3295 as described above.
Synthesis of HCC-amino-D-alanine (HADA)
HADA synthesis was performed according to the protocol of Kuru et al. (2015) , with details provided in the Supporting Information.
Inhibition of cell-wall synthesis and PG labeling
Fosfomycin and bacitracin were used to inhibit cell-wall synthesis. Cells were grown until exponential phase and then incubated in CH medium containing fosfomycin (final concentration 500 lg/ml) or bacitracin (final concentration 500 lg/ml) for 20 min at 308C. To check if cell-wall synthesis was inhibited, cells were labeled with Van-FL or HADA and then imaged. Labeling with Van-FL was performed by incubating the cells with a mixture of 1:1 vancomycin (SigmaAldrich) and BODIPYV R FL Vancomycin (Molecular Probes, Life Technologies) at a final concentration of 1 lg/ml, for 5 min at 308C. For HADA labeling, cells were incubated with HADA (final concentration 0.5 mM) for 5 min at 308C. Excess label was removed by three washes with Phosphate-Buffered Saline (PBS, 58 mM Na 2 HPO 4 ; 17 mM NaH 2 PO 4 ; 68 mM NaCl, pH 7.3). A reverse experiment was performed, in which cells were grown until exponential phase and labeled with HADA (final concentration 0.5 mM) for 5 min at 308C. Cells were then washed three times in PBS and incubated in CH medium (either with or without bacitracin at 500 lg/ml) for an additional 20 min.
Sacculi isolation
Sacculi were purified according to (Atrih et al., 1999) with some modifications. B. subtilis 168 was grown until exponential phase, boiled for 7 min and collected by centrifugation. Cells were resuspended in sodium dodecyl sulfate (SDS, 5% w/v) and boiled for 25 min. The insoluble material was recovered by centrifugation and boiled in SDS (4% w/v) for 15 min. The insoluble material was washed five times in hot Unprocessed PG at B. subtilis division sites 329 water to remove the SDS. Sacculi were digested with 100 lg/ml amylase (Bacillus licheniformis type XII-A in 10 mM Tris-HCl [pH 7.0], 10 mM NaCl, 0.32 M imidazol) for 2 h at 378C and further resuspended in sodium phosphate buffer (50 mM, pH 7.3) containing 100 lg/mL a-chymotrypsin and incubated overnight at 378C. Sacculi were washed with water and resuspended in hydrofluoric acid (48% vol/vol) for 24 h at 48C. Finally, sacculi were washed with Tris-HCl (50 mM, pH7) and cold water until pH was 7.
For HPLC analysis, chymotrypsin treated sacculi were extensively washed with water, resuspended in buffer (50 mM MES, 1 mM MgCl 2 , pH 6.0) to 16.6 mg/ml and 200 ml of the sacculi were digested overnight at 378C with mutanolysin (50 mg/ml) under constantly shaking. Samples were centrifuged for 10 min at 17,000 g and 50 ml of supernatant was analyzed by HPLC on a C18 column (HyperClone TM 5 mm ODS (C18) 120 Å , LC column 250 3 4 mm, 00G-4361-D0 from Phenomenex). The following 290-min-gradient program at a flow rate of 0.5 ml/min was used. Five minutes of washing with 100% buffer A (40 mM sodium phosphate (pH 4.5)) was followed by a linear gradient over 270 min from 0% to 100% buffer B (40 mM sodium phosphate (pH 4) containing 20% (vol/vol) methanol). A 5-min delay and 10 min of re-equilibration with buffer A completed the method. 
Bacterial viability
Bacterial viability after antibiotic treatment was determined by two different assays: the live/dead bacterial viability assay and 10-fold dilution series. Live/dead assay (Life technology) discriminates between cells with or without a compromised membrane using two DNA dyes: the membrane permeable SYTO9 dyes and membrane impermeable propidium iodide. Exponentially growing bacteria were mixed with SYTO 9 dye (0.877 lM), propidium iodide (7.5 lM) and the corresponding antibiotic to be tested (final concentration: fosfomycin 500 lg/ml, bacitracin 500 lg/ml and D-cycloserine 500 lg/ml). Cells were incubated at 308C or 378C (see above). Viability of cells was monitored by microscopy at 20 min and 1 h after antibiotic treatment. Pictures were taken using FITC and TRITC filters.
For the 10-fold dilution series, bacteria were grown as described above and diluted to OD 600 0.4. The corresponding antibiotic (final concentration: fosfomycin 500 lg/ml, bacitracin 500 lg/ml and D-cycloserine 500 lg/ml) was added to the bacteria and cells were further grown for 20 min and 1 h. After this time, the bacteria were rapidly diluted in growth medium in a ten-fold dilution series and 2 ll of each dilution was plated on LB agar. Plates were incubated at 378C overnight.
Fluorescence microscopy
Cells or sacculi were spotted on agarose (1% w/v in PBS) pads and imaged using a Nikon Ti-E microscope (Nikon Instruments, Tokyo, Japan) equipped with a Hamamatsu Orca Flash4.0 camera. Image analysis was performed using the software packages ImageJ (http://rsb.info.nih.gov/ij/), ObjectJ (https://sils.fnwi.uva.nl/bcb/objectj/index.html) and Adobe Photoshop (Adobe Systems Inc., San Jose, CA, USA).
Time-lapse and 3D reconstruction
Time-lapse microscopy was performed as described previously (de Jong et al., 2011) using an DV Elite, IX71 (Olympus, Japan) microscope with a sCMOS camera assembled by Applied Precision (GE Healthcare), with laser excitation at 405 nm (laser power 20%) and a CFP filter. Pictures were taken every 5 min.
Z-stacks were captured with steps of 0.08 lm on the same microscope setup. Deconvolution and 3D reconstruction was performed using Deltavision's Softworx software (Applied Precision).
